For the past month, I have been taking Bacopa extract (daily dose: 300mg) for its purported memory enhancement.
Last week, I was prescribed 27mg of Concerta, which is a extended-release brand of methylphenidate (MPH).
MPH, being a dopamine (DA) and norepinephrine (NE) reuptake inhibitor, has the effect of increasing their (extracellular) concentrations.
Bacopa, as I learned from a recent thread, has been shown to increase DA, meanwhile decreasing NE: Source
BM is known to lower norepinephrine and increase 5-hydroxytryptamine levels in the hippocampus, hypothalamus, an important supervisory center in the brain, rich in ganglia, nerve fibers, and synaptic connections. It is composed of several sections called nuclei, each of which controls a specific function. and cerebral cortex (Singh and Dhawan, 1997).
Source
So, what possible interactions (pharmacologically) might arise from the combination of a NE reuptake inhibitor and something that decreases NE? Are there any (potential) long-term or short-term implications to consider?
Given that Bacopa counteracts the NE increase caused by MPH, I thought I might take it before bed, once the Concerta is wearing off. This way, I'm hope to minimize any interaction between the two and still be able to benefit from Bacopa's memory enhancement.
Will the noradrenergic interaction between the two be avoided this way, if Bacopa is taken during or shortly after the comedown from MPH?
That, I suppose, depends on whether there is still appreciable NE activity during/after the comedown (i.e., if MPH is to some extent still inhibiting NE reuptake). But I'm not sure about that.
Thanks in advance.